Healthcare -
Biotechnology - NASDAQ - US
$ 1.27
1.6 %
$ 145 M
Market Cap
-0.77
P/E
FATE - TOTAL ASSETS
Total Assets FATE - Fate Therapeutics, Inc.
506 M
LAST VALUE
-25.88%
2 YEAR CAGR
18.90%
5 YEAR CAGR
24.72%
10 YEAR CAGR